Business Practice

Sanofi and DNDi are co-developing a drug – acoziborole – to treat sleeping sickness.

Sitting Down With… Will Downie, CEO of Vectura Group, UK, to discuss his career and passion for business.

Novo Nordisk's Stephen Gough explains how pharma can address the cardiovascular risks associated with type 2 diabetes.

We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.

How can we effectively manage the treatment of type 1 diabetes?

Power testing partnership, NASH breakthrough designation, and new CEO appointments. What’s new for pharma in business?

Sitting Down With... Kimberly Eggers, Vice-president of Medical and Clinical Affairs at Aprecia.

Looking back at Trump’s tenure, and the potential implications of the US elections for pharma and the Affordable Health Act.

Graeme Dennis questions why the industry refuses to make use of the significant amount of data it generates.

How is African pharma coping with the COVID-19 pandemic?